<?xml version="1.0" encoding="UTF-8"?>
<p id="Par18">However, to date, the most promising antiviral drug able to fighting COVID-19 is the nucleotide prodrug remdesivir (GS-5734). This drug, recently involved in four phase III clinical trials in China and United States [
 <xref ref-type="bibr" rid="CR25">25</xref>], has a broad spectrum of antiviral activities against RNA viruses like filoviruses, paramyxoviruses, pneumoviruses, SARS and MERS coronavirus [
 <xref ref-type="bibr" rid="CR10">10</xref>].
</p>
